-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622A.O1.6 622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: Bench to Bedside – Tools in Sight of Clinical Practice

Non-Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
W311EFGH, Level 3 (Orange County Convention Center)
Moderators:
Daniela Hoehn, MD, PhD, Columbia University Medical Center and John P. Leonard, MD, Weill Cornell Medical College

Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Barrans Sharon, PhD1*, Andrew J Davies, MRCP2*, Ming Wang3*, Ming-Qing Du, MB, PhD4, Christoph Mamot, MD5*, Keith Pugh, PhD6*, Josh Caddy7*, Matthew A Care, PhD8*, Jan Taylor1*, Reuben M Tooze, PhD, FRCP1,8, Tom Maishman9*, Louise Stanton, PhD6*, Debbie Hamid6*, Andrew McMillan, PhD10, Paul Fields, MD, PhD11, Andrew Jack, PhD, MB1 and Peter Johnson, MD12

1HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
2Southampton University, SCTU, Southampton, United Kingdom
3Department of Pathology, University of Cambridge, Cambridge, United Kingdom
4Dept. Pathology, Div. Histopathology, University of Cambridge, Cambridge, United Kingdom
5Kantonsspital Aarau AG, Aarau, Switzerland
6Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
7University of Southampton, SCTU, Southampton, United Kingdom
8Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom
9SCTU, University of Southampton, Southampton, United Kingdom
10Centre for Clinical Haematology, Nottingham City Hospitals NHS Trust, Nottingham, United Kingdom
11Guys and St Thomas' and Kings College Hospitals, London, United Kingdom
12Cancer Research UK Clinical Centre, University of Southampton, Southampton, United Kingdom

4:45 PM

Maxime Fontanilles1*, Florent Marguet2*, Élodie Bohers1*, Pierre-Julien Viailly3*, Philippe Bertrand, PhD3*, Sydney Dubois4*, Sylvain Mareschal1*, Vincent Camus4*, Elena-Liana Veresezan5*, Philippe Ruminy, PhD3*, Hervé Tilly, MD, PhD3, Annie Laquerriere2*, Jean-Michel Picquenot, PhD5* and Fabrice Jardin, MD, PhD4*

1Cancer Research Center Henri Becquerel, INSERM U918, ROUEN, France
2Charles Nicolle University Hospital, ROUEN, France
3INSERM U918, Centre Henri Becquerel, Rouen, France
4Cancer Research Center Henri Becquerel, INSERM U918, Rouen, France
5Cancer Research Center Henri Becquerel, ROUEN, France

5:00 PM

Jurinovic Vindi, Dipl Math1,2*, Robert Kridel, MD, MPH3, Annette M Staiger, MSc4*, Monika Szczepanowski, PhD5*, Heike Horn, PhD4*, Martin H. Dreyling, MD, PhD1, Andreas Rosenwald, MD6*, German Ott, MD4*, Wolfram Klapper, MD5*, Andrew D. Zelenetz, MD, PhD7, Jonathan W. Friedberg, MD, MMSc8, Stephen Ansell, MD, PhD9, Laurie H. Sehn3, Joseph M Connors, MD3, Randy D. Gascoyne10, David M. Weinstock11, Wolfgang Hiddemann, MD, PhD12*, Michael Unterhalt, PhD1*, Eva Hoster, PhD1,2* and Oliver Weigert, MD12

1Medical Department III, University Hospital of the Ludwig-Maximilians-University, Munich, Germany
2Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital of the Ludwig-Maximilians-University, Munich, Germany
3Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
4Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany
5Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany
6Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany
7Memorial Sloan Kettering Cancer Center, New York, NY
8University of Rochester, Rochester, NY
9Mayo Clinic, Rochester, MN
10British Columbia Cancer Agency, Vancouver, BC, Canada
11Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Department of Internal Medicine III, Ludwig-Maximilians University of Munich, Munich, Germany

5:15 PM

Aliyah R Sohani, MD1, Brandy Pitcher, MS2*, Amy Chadburn, MD3, Jonathan W. Said, MD4*, Peter Martin, MD5, Myron S. Czuczman, MD6, Nancy L Bartlett, MD7, Cara A. Rosenbaum, MD8, John P. Leonard, MD9, Bruce D. Cheson, MD10 and Eric D. Hsi, MD11

1Department of Pathology, Massachusetts General Hospital, Boston, MA
2Alliance Statistics and Data Center, Duke University, Durham, NC
3Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY
4Department of Pathology, UCLA Medical Center, Los Angeles, CA
5Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
6Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY
7Washington University School of Medicine, Saint Louis, MO
8University of Chicago Medical Center, Chicago, IL
9Department of Medicine, Weill Cornell Medical College, New York, NY
10Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
11Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH

5:30 PM

Caroline Bodet-Milin1*, Clement Bailly1*, Michel Meignan2*, Alina Beriollo-Riedinger3*, Rene-Olivier Casasnovas, MD4*, Anne Devillers5*, Thierry Lamy, PhD, MD6, Maria Santiago-Ribeiro7*, Emmanuel Gyan, MD, PhD8, Céline Gallazzini-Crépin9*, Remy Gressin, MD10, Thomas Carlier11*, Francoise Kraeber-Bodéré12*, Olivier Hermine13* and Steven Le Gouill, MD, PhD14*

1CHU de Nantes, Nantes, France
2CHU Henri Mondor, Créteil, France
3centre georges françois Leclerc, Dijon, France
4Hematology, University Hospital, Dijon, France
5CRLCC, Rennes, France
6Service Hematologie Clinique, Hospital Pontchaillou, Rennes, France
7CHU Tours, Tours, France
8Service d'Hématologie et thérapie cellulaire, Centre Hospitalier Universitaire, Tours, France
9CHU Grenoble, grenoble, France
10Service d'hématologie clinique, CHU Grenoble, Grenoble, France
11CHU Nantes, Nantes, France
12CHU de Nantes, nantes, France
13Department of Hematology, Necker Children's hospital, APHP, Paris, France
14Department of Hematology, Nantes University Hospital, Nantes, France

5:45 PM

Davide Rossi, MD, PhD1, Simone Ferrero2*, Alessio Bruscaggin3*, Paola Ghione2*, Alice Di Rocco4*, Valeria Spina3*, Vittorio Stefoni5*, Giovannino Ciccone6*, Daniela Barbero2*, Luigia Monitillo2*, Maria Gomes Da Silva7*, Armando Santoro, MD8*, Annalia Molinari9*, Andres J.M. Ferreri10, Sergio Cortelazzo11, Marco Ladetto12 and Gianluca Gaidano3*

1Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
2Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Torino, Italy
3Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
4Policlinico Umberto I, Roma, Italy
5Institute of Hematology, University of Bologna, Bologna, Italy
6Unit of Clinical Epidemiology, A.O.U. Citta' della Salute e della Scienza di Torino, Torino, Italy
7Portuguese Institute of Oncology, Lisbon, Portugal
8Fondazione ‘G.Pascale’, IRCCS, Istituto Nazionale Tumori, Naples, Italy
9Department of Oncology and Hematology, Infermi Hospital, Rimini, Italy, Rimini, Italy
10Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Milano, Italy
11Department of Haematology and Bone Marrow Transplantation, Regional Hospital, S. Maurizio, Bolzano/Bozen, Italy
12Division of Hematology, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

*signifies non-member of ASH